JESSICA PECEVICH: Open Payments
NPI 1952076564 · AVON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 18 payments from 5 companies in 2025. Trend: 2023 $637 · 2024 $462 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $386 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| ACADIA Pharmaceuticals Inc | 1 | $28 |
| Neurelis, Inc. | 1 | $15 |
Products named: INGREZZA, CAPLYTA, REXULTI, NUPLAZID, VALTOCO.
Industry payments across CT — which companies pay providers there.
